Cargando…
An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss
BACKGROUND: Facial filler injection techniques that help decrease the risk of vascular occlusion are an important growing area of study. This study demonstrates a model of injecting fillers into a simulated bifurcated arterial system, using different sized needle gauges at a constant injection press...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499102/ https://www.ncbi.nlm.nih.gov/pubmed/37711726 http://dx.doi.org/10.1097/GOX.0000000000005270 |
_version_ | 1785105647043346432 |
---|---|
author | Scott, Gabriel Khonda, Meghana Hsu, Tammy Rivkin, Alexander Frank, Konstantin Fezza, John Woodward, Julie |
author_facet | Scott, Gabriel Khonda, Meghana Hsu, Tammy Rivkin, Alexander Frank, Konstantin Fezza, John Woodward, Julie |
author_sort | Scott, Gabriel |
collection | PubMed |
description | BACKGROUND: Facial filler injection techniques that help decrease the risk of vascular occlusion are an important growing area of study. This study demonstrates a model of injecting fillers into a simulated bifurcated arterial system, using different sized needle gauges at a constant injection pressure. METHODS: Three facial fillers were injected into a bifurcated intravenous tubing with continuous irrigation at a constant pressure to simulate a vascular system. Videography was used to observe for retrograde flow through the simulated supratrochlear artery to the bifurcation point, where the filler was redirected by anterograde flow into the branch representing the ophthalmic artery. RESULTS: Filler injection with retrograde flow to the bifurcation occurred with all the 27G needle trials. In comparison, the 30G needle trials were only able to reach the bifurcation point in three of the nine trials. The average time to the bifurcation point with subsequent ophthalmic artery anterograde flow with the 27G and 30G needles were 8.44 (95% confidence interval ±2.06) and 33.33 (95% confidence interval ±16.56) seconds, respectively. CONCLUSIONS: Larger 27G needles consistently reached retrograde flow and the bifurcation point faster than 30G needles. This study suggests thinner needles may be less likely to cause retrograde occlusion. |
format | Online Article Text |
id | pubmed-10499102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104991022023-09-14 An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss Scott, Gabriel Khonda, Meghana Hsu, Tammy Rivkin, Alexander Frank, Konstantin Fezza, John Woodward, Julie Plast Reconstr Surg Glob Open Cosmetic BACKGROUND: Facial filler injection techniques that help decrease the risk of vascular occlusion are an important growing area of study. This study demonstrates a model of injecting fillers into a simulated bifurcated arterial system, using different sized needle gauges at a constant injection pressure. METHODS: Three facial fillers were injected into a bifurcated intravenous tubing with continuous irrigation at a constant pressure to simulate a vascular system. Videography was used to observe for retrograde flow through the simulated supratrochlear artery to the bifurcation point, where the filler was redirected by anterograde flow into the branch representing the ophthalmic artery. RESULTS: Filler injection with retrograde flow to the bifurcation occurred with all the 27G needle trials. In comparison, the 30G needle trials were only able to reach the bifurcation point in three of the nine trials. The average time to the bifurcation point with subsequent ophthalmic artery anterograde flow with the 27G and 30G needles were 8.44 (95% confidence interval ±2.06) and 33.33 (95% confidence interval ±16.56) seconds, respectively. CONCLUSIONS: Larger 27G needles consistently reached retrograde flow and the bifurcation point faster than 30G needles. This study suggests thinner needles may be less likely to cause retrograde occlusion. Lippincott Williams & Wilkins 2023-09-13 /pmc/articles/PMC10499102/ /pubmed/37711726 http://dx.doi.org/10.1097/GOX.0000000000005270 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Cosmetic Scott, Gabriel Khonda, Meghana Hsu, Tammy Rivkin, Alexander Frank, Konstantin Fezza, John Woodward, Julie An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss |
title | An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss |
title_full | An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss |
title_fullStr | An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss |
title_full_unstemmed | An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss |
title_short | An Experimental Model Exhibiting Anterograde and Retrograde Vascular Occlusion of Facial Fillers to Avoid Vision Loss |
title_sort | experimental model exhibiting anterograde and retrograde vascular occlusion of facial fillers to avoid vision loss |
topic | Cosmetic |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499102/ https://www.ncbi.nlm.nih.gov/pubmed/37711726 http://dx.doi.org/10.1097/GOX.0000000000005270 |
work_keys_str_mv | AT scottgabriel anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT khondameghana anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT hsutammy anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT rivkinalexander anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT frankkonstantin anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT fezzajohn anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT woodwardjulie anexperimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT scottgabriel experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT khondameghana experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT hsutammy experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT rivkinalexander experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT frankkonstantin experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT fezzajohn experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss AT woodwardjulie experimentalmodelexhibitinganterogradeandretrogradevascularocclusionoffacialfillerstoavoidvisionloss |